iPierian, Inc., a biotechnology company developing novel therapies for neurodegenerative diseases, announced today that it will make a presentation of a preclinical study from its Tau antibody program at the Society for Neuroscience annual meeting taking place November 9-13, 2013, in San Diego, CA.
Help employers find you! Check out all the jobs and post your resume.
